Early Phase 1 Sickle Cell Disease Clinical Trials
2 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–2 of 2 trials
Recruiting
Early Phase 1
Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
Sickle Cell DiseaseThalassemiaHemoglobinopathy
National Heart, Lung, and Blood Institute (NHLBI)100 enrolled1 locationNCT06313398
Recruiting
Early Phase 1
CS-206 in Patients With Sickle Cell Disease
Sickle Cell Disease
CorrectSequence Therapeutics Co., Ltd5 enrolled1 locationNCT06565026